2019 Volume 34 Issue 1 Pages 21-27
Type II endoleak after EVAR or TEVAR in the treatment of aortic aneurysms is a growing concern since a substantial population shows sac enlargement due to type II endoleak and that compromises the durability of the treatments. There are miscellaneous approaches reported in the literature in the intervention to address these issues; however, we focus on transarterial or percutaneous approach in this review. We also address the limitation of endovascular treatment of type II endoleak after EVAR. Additionally, embolization of type II endoleak after TEVAR is discussed.